Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medtronic plcMDT · Entity 2888 | Director | May 03, 2021 | May 04, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medtronic plc
Report date May 03, 2021 · Filed May 04, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 57,849 |
Reported balance
After 2021-05-03 transaction · row 1
1 source rowRow 1 · 2021-05-03 · Grant · Acquired 1,334 · Balance 57,849 F1: This restricted stock unit award will vest on the one year anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: This restricted stock unit award will vest on the one year anniversary of the grant date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
JOHNSON & JOHNSON
Report date June 30, 2004 · Filed July 01, 2004
Section 16 reporting ended · disclosed 2004-07-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Indirect401 (k) and ESOP Savings Plans | 8,645 |
Reported balance
After 2004-05-31 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2004-05-31 · Other · Acquired 46 · Balance 8,645 F1: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (05/31/2004). |
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 16,568 |
Reported balance
After 2004-06-30 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2004-06-30 · Other · Acquired 84 · Balance 16,568 F3: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 30, 2004 at $55.48 per share are to be settled in cash upon the Reporting Person's Retirement. F4: The Phantom Stock converts into common stock on a one-for-one basis. |
| CommonSEC Table I · non-derivative | Direct | 198,157 |
Reported balance
Holding disclosure · report date 2004-06-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 198,157 |
| CommonSEC Table I · non-derivative | IndirectIn Custody for Son | 1,880 |
Reported balance
Holding disclosure · report date 2004-06-30 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,880 F2: Held in custody for son. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (05/31/2004).
F2: Held in custody for son. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F3: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 30, 2004 at $55.48 per share are to be settled in cash upon the Reporting Person's Retirement.
F4: The Phantom Stock converts into common stock on a one-for-one basis.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 03, 2021 Filed May 4, 2021 17:50 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 1,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-015322 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,849 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. Read SEC document |
| April 27, 2021 Filed Apr 28, 2021 18:37 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 426 | $129.97 | $55,367.22 |
DisclosureSEC source: 0001127602-21-014587 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,515 F1 · balance_after: This balance increased by 514 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 18:33 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 393 | $99.14 | $38,962.02 |
DisclosureSEC source: 0001127602-20-014921 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,427 Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 18:24 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 1,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014690 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,820 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 363 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| September 25, 2019 Filed Sep 26, 2019 18:20 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,813 | $0.00 Strike: $44.13 | $0.00 |
DisclosureSEC source: 0001127602-19-029170 · form4.xml · derivative · entry 3 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,813 shares Expires 2020-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 1,813 New Medtronic ordinary shares for $44.13 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,813 Medtronic common stock shares for $44.13 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| September 25, 2019 Filed Sep 26, 2019 18:20 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 744 | $107.62 | $80,069.28 |
DisclosureSEC source: 0001127602-19-029170 · form4.xml · nonDerivative · entry 2 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,720 Read SEC document |
| September 25, 2019 Filed Sep 26, 2019 18:20 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 1,813 | $44.13 | $80,007.69 |
DisclosureSEC source: 0001127602-19-029170 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This balance increased by 129 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 30, 2019 Filed May 1, 2019 16:24 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 429 | $88.81 | $38,099.49 |
DisclosureSEC source: 0001127602-19-016732 · form4.xml · nonDerivative · entry 2 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,522 Read SEC document |
| April 30, 2019 Filed Jun 12, 2019 18:13 UTC Amendment | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 429 | $88.81 | $38,099.49 |
DisclosureSEC source: 0001127602-19-021493 · form4a.xml · nonDerivative · entry 2 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,522 Read SEC document |
| April 29, 2019 Filed May 1, 2019 16:24 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 2,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-016732 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,951 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased 141 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 29, 2019 Filed Jun 12, 2019 18:13 UTC Amendment | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 2,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-021493 · form4a.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,951 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 141 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| March 04, 2019 Filed Mar 5, 2019 18:36 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,671 | $0.00 Strike: $29.96 | $0.00 |
DisclosureSEC source: 0001127602-19-010036 · form4.xml · derivative · entry 2 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,671 shares Expires 2019-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| March 04, 2019 Filed Mar 5, 2019 18:36 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 2,671 | $29.96 | $80,023.16 |
DisclosureSEC source: 0001127602-19-010036 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This balance increased by 403 shares due to exempt transactions such as dividend reinvestment Read SEC document |
| May 01, 2018 Filed May 2, 2018 15:07 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 616 | $81.01 | $49,902.16 |
DisclosureSEC source: 0001127602-18-015926 · form4.xml · nonDerivative · entry 2 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,734 Read SEC document |
| April 30, 2018 Filed May 2, 2018 15:07 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015926 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,350 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased 139 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 17:27 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,590 | $0.00 Strike: $50.34 | $0.00 |
DisclosureSEC source: 0001127602-18-011591 · form4.xml · derivative · entry 3 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,590 shares Expires 2018-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 1,590 New Medtronic ordinary shares for $50.34 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,590 Medtronic common stock shares for $50.34 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 17:27 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 1,306 | $83.56 | $109,122.83 |
DisclosureSEC source: 0001127602-18-011591 · form4.xml · nonDerivative · entry 2 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,028 Read SEC document |
| March 13, 2018 Filed Mar 14, 2018 17:27 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 1,590 | $50.34 | $80,040.60 |
DisclosureSEC source: 0001127602-18-011591 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This balance increased 391 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| July 10, 2017 Filed Jul 11, 2017 15:16 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,010 | $0.00 Strike: $52.84 | $0.00 |
DisclosureSEC source: 0001127602-17-023489 · form4.xml · derivative · entry 2 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,010 shares Expires 2017-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option to purchase 1,010 New Medtronic ordinary shares for $52.84 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,010 Medtronic common stock shares for $52.84 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| July 10, 2017 Filed Jul 11, 2017 15:16 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 1,010 | $52.84 | $53,368.40 |
DisclosureSEC source: 0001127602-17-023489 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2017 Filed May 31, 2017 16:28 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 647 | $85.09 | $55,053.23 |
DisclosureSEC source: 0001127602-17-019836 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,343 Read SEC document |
| May 01, 2017 Filed May 3, 2017 16:01 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 2,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-016600 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,990 F1 · security: This balance increased 261 shares due to exempt transactions such as dividend reinvestment. F2 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 14:41 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 801 | $0.00 Strike: $54.14 | $0.00 |
DisclosureSEC source: 0001127602-17-001264 · form4.xml · derivative · entry 4 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 801 shares Expires 2017-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 801 New Medtronic ordinary shares for $54.14 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 801 Medtronic common stock shares for $54.14 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 14:41 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,586 | $0.00 Strike: $54.14 | $0.00 |
DisclosureSEC source: 0001127602-17-001264 · form4.xml · derivative · entry 3 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 801 Underlying: Ordinary Shares · 2,586 shares Expires 2017-01-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option to purchase 2,586 ordinary shares of New Medtronic for $54.14 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,586 Medtronic common stock shares for $54.14 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 14:41 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 801 | $54.14 | $43,366.14 |
DisclosureSEC source: 0001127602-17-001264 · form4.xml · nonDerivative · entry 2 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,639 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 14:41 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 2,586 | $54.14 | $140,006.04 |
DisclosureSEC source: 0001127602-17-001264 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2016 Filed Nov 23, 2016 12:32 UTC | Medtronic plc MDT · Entity 2888 | PurchaseOrdinary Shares | 2,000 | $73.27 | $146,532.60 |
DisclosureSEC source: 0001127602-16-068289 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,252 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $73.245 to $73.27, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4. F2 · balance_after: This balance increased by 119 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| June 30, 2004 Filed Jul 1, 2004 14:57 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherPhantom Stock Units · Derivative | 84 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000200406-04-000104 · edgar.xml · derivative · entry 4 LENEHAN JAMES T · CIK 0001189009 · Former Vice Chairman/Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,568 Underlying: Common · 84 shares Expires not disclosed F3 · security: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 30, 2004 at $55.48 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F3 · price: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 30, 2004 at $55.48 per share are to be settled in cash upon the Reporting Person's Retirement. F3 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 30, 2004 at $55.48 per share are to be settled in cash upon the Reporting Person's Retirement. F3 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on June 30, 2004 at $55.48 per share are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| May 31, 2004 Filed Jul 1, 2004 14:57 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 46 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-04-000104 · edgar.xml · nonDerivative · entry 2 LENEHAN JAMES T · CIK 0001189009 · Former Vice Chairman/Director 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (k) and ESOP Savings Plans Disclosed balance after: 8,645 F1 · security: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (05/31/2004). F1 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (05/31/2004). Read SEC document |
| March 31, 2004 Filed Apr 2, 2004 16:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherPhantom Stock Units · Derivative | 78 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000200406-04-000068 · edgar.xml · derivative · entry 4 LENEHAN JAMES T · CIK 0001189009 · Former Vice Chairman/Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,484 Underlying: Common · 78 shares Expires not disclosed F3 · security: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on March 31, 2004 at $50.56 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F3 · price: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on March 31, 2004 at $50.56 per share are to be settled in cash upon the Reporting Person's Retirement. F3 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on March 31, 2004 at $50.56 per share are to be settled in cash upon the Reporting Person's Retirement. F3 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on March 31, 2004 at $50.56 per share are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| March 31, 2004 Filed Apr 2, 2004 16:25 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 74 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-04-000068 · edgar.xml · nonDerivative · entry 2 LENEHAN JAMES T · CIK 0001189009 · Former Vice Chairman/Director 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (k) and ESOP Savings Plans Disclosed balance after: 8,599 F1 · security: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (03/31/2004). F1 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (03/31/2004). Read SEC document |
| February 09, 2004 Filed Feb 11, 2004 18:08 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherPhantom Stock Units · Derivative | 2,480 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000200406-04-000024 · edgar.xml · derivative · entry 4 LENEHAN JAMES T · CIK 0001189009 · Former Vice Chairman/Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,406 Underlying: Common · 2,480 shares Expires not disclosed F4 · security: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 9, 2004 at $53.93 per share are to be settled in cash upon the Reporting Person's Retirement. F5 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F4 · price: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 9, 2004 at $53.93 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 9, 2004 at $53.93 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan on February 9, 2004 at $53.93 per share are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| February 05, 2004 Filed Feb 11, 2004 18:08 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GiftCommon | 405 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-04-000024 · edgar.xml · nonDerivative · entry 3 LENEHAN JAMES T · CIK 0001189009 · Former Vice Chairman/Director 10b5-1 filing: Not disclosed Ownership: Indirect · In Custody for Son Disclosed balance after: 1,880 F1 · price: Gift F3 · balance_after: Held in custody for son. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| February 05, 2004 Filed Feb 11, 2004 18:08 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GiftCommon | 1,215 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-04-000024 · edgar.xml · nonDerivative · entry 1 LENEHAN JAMES T · CIK 0001189009 · Former Vice Chairman/Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,157 F1 · price: Gift Read SEC document |
| January 30, 2004 Filed Feb 11, 2004 18:08 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 16 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-04-000024 · edgar.xml · nonDerivative · entry 2 LENEHAN JAMES T · CIK 0001189009 · Former Vice Chairman/Director 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (k) and ESOP Savings Plans Disclosed balance after: 8,525 F2 · security: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (01/30/2004). F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plans' most recent reporting date (01/30/2004). Read SEC document |
| January 21, 2004 Filed Jan 22, 2004 14:12 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 230,800 | $13.41 Strike: $13.41 | $3,095,028.00 |
DisclosureSEC source: 0000200406-04-000011 · edgar.xml · derivative · entry 8 LENEHAN JAMES T · CIK 0001189009 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 230,800 shares Expires 2004-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Awarded under Issuer's Stock Option Plan and exercisable in increments of 20% per year starting two years from date of grant. F1 · derivative.exercise_price: Adjusted to reflect two-for-one stock splits in 1996 and 2001. F1 · price: Adjusted to reflect two-for-one stock splits in 1996 and 2001. Read SEC document |
| January 21, 2004 Filed Jan 22, 2004 14:12 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon | 177,500 | $51.60 | $9,159,000.00 |
DisclosureSEC source: 0000200406-04-000011 · edgar.xml · nonDerivative · entry 4 LENEHAN JAMES T · CIK 0001189009 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,372 Read SEC document |
| January 21, 2004 Filed Jan 22, 2004 14:12 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon | 37,600 | $51.62 | $1,940,912.00 |
DisclosureSEC source: 0000200406-04-000011 · edgar.xml · nonDerivative · entry 3 LENEHAN JAMES T · CIK 0001189009 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,872 Read SEC document |
| January 21, 2004 Filed Jan 22, 2004 14:12 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon | 15,700 | $51.64 | $810,748.00 |
DisclosureSEC source: 0000200406-04-000011 · edgar.xml · nonDerivative · entry 2 LENEHAN JAMES T · CIK 0001189009 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,472 Read SEC document |
| January 21, 2004 Filed Jan 22, 2004 14:12 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon | 230,800 | $13.41 | $3,095,028.00 |
DisclosureSEC source: 0000200406-04-000011 · edgar.xml · nonDerivative · entry 1 LENEHAN JAMES T · CIK 0001189009 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 430,172 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Adjusted to reflect two-for-one stock splits in 1996 and 2001. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 19:10 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherPhantom Stock Units · Derivative | 65 | $51.31 Strike: $0.00 | $3,335.15 |
DisclosureSEC source: 0000200406-04-000006 · edgar.xml · derivative · entry 4 LENEHAN JAMES T · CIK 0001189009 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,926 Underlying: Common · 65 shares Expires not disclosed F3 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan as of December 31, 2003 at $51.31 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.expiration_date: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan as of December 31, 2003 at $51.31 per share are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.underlying_shares: The Phantom Stock Units acquired under the Issuer's Executive Income Deferral Plan as of December 31, 2003 at $51.31 per share are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| December 31, 2003 Filed Jan 5, 2004 19:10 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 38 | $0.00 | $0.00 |
DisclosureSEC source: 0000200406-04-000006 · edgar.xml · nonDerivative · entry 2 LENEHAN JAMES T · CIK 0001189009 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (k) and ESOP Savings Plans Disclosed balance after: 8,509 F1 · security: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of 12/31/2003. F1 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans as of 12/31/2003. Read SEC document |
| November 07, 2003 Filed Nov 10, 2003 15:07 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,000 | $11.07 Strike: $11.07 | $88,560.00 |
DisclosureSEC source: 0000200406-03-000053 · edgar.xml · derivative · entry 5 LENEHAN JAMES T · CIK 0001189009 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 8,000 shares Expires 2003-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Awarded under Issuer's Stock Option Plan and exercisable in increments of 20% per year starting two years from date of grant. F1 · derivative.exercise_price: Adjusted to reflect two-for-one stock splits in 1996 and 2001. F1 · price: Adjusted to reflect two-for-one stock splits in 1996 and 2001. Read SEC document |
| November 07, 2003 Filed Nov 10, 2003 15:07 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon | 8,000 | $11.07 | $88,560.00 |
DisclosureSEC source: 0000200406-03-000053 · edgar.xml · nonDerivative · entry 1 LENEHAN JAMES T · CIK 0001189009 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,372 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Adjusted to reflect two-for-one stock splits in 1996 and 2001. Read SEC document |
| September 30, 2003 Filed Oct 2, 2003 13:41 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherPhantom Stock Units · Derivative | 67 | $49.55 Strike: $0.00 | $3,319.85 |
DisclosureSEC source: 0000200406-03-000038 · edgar.xml · derivative · entry 4 LENEHAN JAMES T · CIK 0001189009 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,861 Underlying: Common · 67 shares Expires not disclosed F3 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: The Phantom Stock Units were acquired under the Issuer's Executive Income Deferral Plan on September 30, 2003 at $49.55 per share and are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.expiration_date: The Phantom Stock Units were acquired under the Issuer's Executive Income Deferral Plan on September 30, 2003 at $49.55 per share and are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| September 30, 2003 Filed Oct 2, 2003 13:41 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 39 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000200406-03-000038 · edgar.xml · nonDerivative · entry 2 LENEHAN JAMES T · CIK 0001189009 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (k) and ESOP Savings Plans Disclosed balance after: 8,471 F1 · security: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plan's most recent reporting date (09/30/2003). F1 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plan's most recent reporting date (09/30/2003). Read SEC document |
| July 31, 2003 Filed Jul 31, 2003 18:19 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherPhantom Stock Units · Derivative | 78 | $50.88 Strike: $0.00 | $3,968.64 |
DisclosureSEC source: 0001189009-03-000017 · edgar.xml · derivative · entry 4 LENEHAN JAMES T · CIK 0001189009 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,794 Underlying: Common · 78 shares Expires not disclosed F3 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: The Phantom Stock Units were acquired under the Issuer's Executive Income Deferral Plan on July 31, 2003 at $50.88 per share and are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.expiration_date: The Phantom Stock Units were acquired under the Issuer's Executive Income Deferral Plan on July 31, 2003 at $50.88 per share and are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| June 30, 2003 Filed Jul 2, 2003 15:55 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherPhantom Stock Units · Derivative | 1,243 | $51.65 Strike: $0.00 | $64,200.95 |
DisclosureSEC source: 0001189009-03-000016 · edgar.xml · derivative · entry 4 LENEHAN JAMES T · CIK 0001189009 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,716 Underlying: Common · 1,243 shares Expires 1988-08-08 F3 · derivative.exercise_price: The Phantom Stock converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: The Phantom Stock Units were acquired under the Issuer's Executive Income Deferral Plan on June 30, 2003 at $ 51.65 per share and are to be settled in cash upon the Reporting Person's Retirement. F4 · derivative.expiration_date: The Phantom Stock Units were acquired under the Issuer's Executive Income Deferral Plan on June 30, 2003 at $ 51.65 per share and are to be settled in cash upon the Reporting Person's Retirement. Read SEC document |
| June 30, 2003 Filed Jul 2, 2003 15:55 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | OtherCommon | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0001189009-03-000016 · edgar.xml · nonDerivative · entry 2 LENEHAN JAMES T · CIK 0001189009 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · 401 (k) and ESOP Savings Plan Disclosed balance after: 8,432 F2 · security: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plan's most recent reporting date (06/30/2003). F2 · date: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plan's most recent reporting date (06/30/2003). F2 · shares: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plan's most recent reporting date (06/30/2003). F2 · price: Shares acquired under Johnson & Johnson's 401(k) and ESOP Savings Plans at Plan's most recent reporting date (06/30/2003). Read SEC document |
| June 13, 2003 Filed Jul 2, 2003 15:55 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GiftCommon | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001189009-03-000016 · edgar.xml · nonDerivative · entry 3 LENEHAN JAMES T · CIK 0001189009 · Director · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · In Custody for Son Disclosed balance after: 1,475 F1 · balance_after: Held in custody for son. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.